Clinical Perspectives on the Treatment of Melanoma
Physician Continuing Medical Education

Click here to download Clinical Perspectives on the Treatment of Melanoma.
Click here to take the CME test and evaluation on line

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and PharmAdura, LLC. PIM is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.5 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

Nursing Continuing Education

CNA/ANCC

This educational activity for 1.9 contact hours is provided by Postgraduate Institute for Medicine (PIM). PIM is an approved provider of continuing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

California Board of Registered Nursing

Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485 for 1.9 contact hours.

Target Audience

This activity has been designed to meet the educational needs of dermatologists, surgical oncologists, general surgeons, medical oncologists, and oncology nurses involved in the management of patients with melanoma.

Purpose

To present the advances in treatment modalities for melanoma

Learning Objectives

After completion of this activity, participants will be better able to:

• Describe the evolution of the AJCC staging system, including the rationale behind planned revisions underway
• Describe adjuvant and neoadjuvant opportunities and hurdles in melanoma
• Explain strategies for managing side effects in patients receiving high-dose IFN alfa-2b therapy
• Describe the role of surgery in management of limited distant metastatic melanoma
• Explain the technique of isolated limb perfusion
• Describe the role of isolated limb perfusion in the treatment of multiple bulky in-transit melanoma metastases limited to the extremities

Release date: February 2006
Expiration date: March 2007
Estimated time to complete activity: 1.5 hours

Faculty

John M. Kirkwood, MD
Director, Melanoma and Skin Cancer Program
University of Pittsburgh Cancer Institute
Professor and Vice Chairman for Clinical Research
Department of Medicine
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania

Susan M. Swetter, MD
Associate Professor of Dermatology
Director, Pigmented Lesion & Cutaneous Melanoma Clinic
Stanford University Medical Center/VA Palo Alto Health Care System
Codirector, Stanford Multidisciplinary Melanoma Clinic
Stanford, California

Jeffrey E. Gershenwald, MD
Associate Professor of Surgery and Cancer Biology
The University of Texas M. D. Anderson Cancer Center
Houston, Texas

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter - Reported Financial Relationship

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner or Manager - Reported Financial Relationship

Media

Monograph